ÂÜÀòÂÒÂ×

Rick Blidner currently holds the position of Vice President of Molecular Assay Development at Tempus Labs, Inc., where responsibilities include leading product development and streamlining processes across departments. Previous roles encompass Senior Director of Molecular Assay Development at Tempus Labs, R&D Site Leader and Senior Manager Diagnostics at PerkinElmer, and Group Leader at Asuragen, where significant contributions included the development of the QuantideX NGS RNA Lung Cancer Kit and strategic technology scouting resulting in substantial acquisition offers. Earlier experiences include Principal Scientist at Nanomix, where innovations in biosensors and microfluidic technologies were realized, and various roles at Investigen, Louisiana State University, Southern Eye Bank, and Central Ohio Lyons Eye Bank. Academic credentials include a PhD in Bioengineering and Biochemistry from Louisiana State University, an MS in Biomedical Engineering from The Ohio State University, and a BS in Biomedical Engineering from Tulane University.